PTSM: Pharmaceutical Technology Sourcing and Management
The company announced its new ISQ EC Single Quadrupole mass spectrometer and the new range of Thermo Scientific MAbPac RP 1-mm columns.
On June 19, 2017 Thermo Fisher Scientific announced new technologies designed to allow analytical chemists to obtain high-resolution separations. The company is displaying the new technologies at the 46th International Symposium on High Performance Liquid Phase Separations and Related Techniques from June 18–22, 2017, at the Prague Congress Centre.
The new Thermo Scientific ISQ EC Single Quadrupole mass spectrometer (MS) integrates with an existing ion chromatography (IC) or high performance liquid chromatography (HPLC) system and provides small molecule sensitivity and mass confirmation. The Chromeleon Chromatography Data Software platform has embedded ISQ EC MS instrument control, which enables users to minimize time spent on new MS user training. The instrument also enables users to analyze a range of simple and complex sample matrices.
The new range of Thermo Scientific MAbPac RP 1-mm columns are designed for high-performance, reversed-phase chromatography characterization of monoclonal antibodies, fragments, variants, antibody drug conjugates, and proteins. With a 1-mm inner diameter, the new columns provide sensitive analyses of very small sample volumes at low flow rates for direct injection into the LC-MS. The columns include a polymeric resin with an optimized pore size and thermal and pH stability.
Source: Thermo Fisher Scientific
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.